Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
" NO MORE PARTNERSHIPS"
I call it a classic case of temporary exhaustion.. I saw it yesterday in the stock action..
Brief essay on AP1903 that I didn't see before:
http://www.ariad.com/wt/tertiarypage/AP1903
HB at JPM, tomorrow 1P EST - That's why I skimmed a little. The market may expect some type of "news", and if it is the generic slides again, the market might be disappointed..
I just skimmed some off the table.. what a fricken, amazing run..
What will be our next source of "fuel" to keep this going?
Look at the volume over the last week- I was thinking the same thing, and I expect that was the fuel that moved us up.. Those guys paid a heavy price, and not too bright..
Check out the short interest...
http://www.nasdaq.com/symbol/aria/short-interest
"We are not for sale", but Harvey is 60-61.. He might take $30.. And it seems to be following the script..slowly up most days until finally.. Boom.
2damoon1, thank you for your outstanding work with the 2012 list.. You and the board exceeded what I expected. Thank you as well for your fair and unbiased "policing" of this board. Hopefully, you will stay in your position for many months, or at least wait until the third split in Ariad stock..
If you want to ride it back down to $7, that's your business.. LOL. What on earth are you talking about?
Let's follow the DNDN path.. With little revenue, and 149 million shares outstanding, the market cap reached 6.2 billion @ $42 per share not long ago. Let's hope history can repeat itself one more Time...
Would like to see a melt up.. We have not seen that yet.. This has been very civilized so far..
There must have been some short covering over the last few days..
2damoon1, could you please update the third sticky note (upcoming events)? I would like to see if we can fill in the gap of news events for the next 6 months. Guess the JP Morgan conference is one. Thanks..
Biogen CEO: New Year Is 'Remarkable Time' For Biotech
No mention of Ariad, but interesting..
http://news.investors.com/Article/595922/201112271635/biogen-ceo-predicts-2012-biotech-trends.htm
Or, this big shaker that Ariad just experienced.. Marty, me boy:
13. “If a former executive from Big Pharma joins a small biotech company, it means the small company must be a winner!”
DewDilly, don't forget #1.. ROTFLMAO
1. “If a drug does something notable in animals, it must be safe and effective for humans.”
OT.. Here is a good example from the 1950's that proves humans can be clueless.
Here is an ad where a cold cream company adds radioactive particles (as a test) to their cold cream to prove to women that their cold cream is better than the competitors.
Lord, save us..
Make it a buck, and call it a day...
07:52 ARIA Ariad Pharm target raised to $18 at Rodman & Renshaw after ASH and financing (11.74 )
Rodman & Renshaw raises their ARIA tgt to $18 from $15. After a relatively quiet November, ARIA has had an eventful December, releasing updated preliminary results of the PACE trial at the American Society of Hematology (ASH) conference and completing a $258mm public offering of common stock. While both events were not unexpected, firm believes the successful execution of each speaks to the strength of ponatinib and the co's mgmt.
Posted on YAHOO, so I'll look for the link elsewere for verification..
biomaven0, thank you so very much.. You make visiting this board so worth while....
Wow, if you can't accept the fact that the Baker Brothers bought ANOTHER 6 million shares of Ariad as being positive, I'm not sure what to tell ya....
Good brief reference to Ariad, Baker Brothers, CML, and '113...
http://www.investorplace.com/2011/12/ariad-pharmaceuticals-aria-ponatinib-leukemia/
BTH, you can thank me later.... you must of missed this: Frm Dow Jones
News for 'ARIA' - (*DJ Ariad Files Mixed-Securities Shelf)
(MORE TO FOLLOW) Dow Jones Newswires (212-416-2400)
December 14, 2011 16:03 ET (21:03 GMT)
Copyright (c) 2011 Dow Jones & Company, Inc.- - 04 03 PM EST 12-14-11
The PR indicated mixed offering,so I wasn't sure..
When they set the date, there would be question the stock would be placed..
I didn't see the details of the mixed shelf.. How much was preferred stock? Any bonds? Had to be mixed somehow..
Ariad said they would complete the public offering by December 20th, and they did it.. These guys are good, LOL... Never doubt the intestinal fortitude of the Harv-ster. They must of force fed it, LOL..
As far as the general market goes, I just love short covering rallies...
Merck(MRK_) and Ariad Pharmaceuticals(ARIA_)
Drug/indication: ridaforolimus for sarcoma.
Approval decision date: June 5, 2012
My question revolves around that, according to the article, a diagnostic test MUST be developed for Pona Approval.. What is that risk that the test can be developed in time for the NDA filing? They obviously can determine if the mutant exists, but you need a convenient, robust test for the many patients that will be screened.
Is there a risk here with our investment in Ariad, on the certainty of MolecularMD creating a viable diagnostic test? One of those known unknowns..
A main issue for the approval in T315I patients will be having a commercially available diagnostic kit that can identify the mutation, as the FDA will probably view it as a condition for approval. Ariad is working with MolecularMD on developing diagnostic test specifically for this purpose.
Thank you Peter for sharing you incredible knowledge.
I had to look it up, and I'm sure others want to know what it means:
http://www.marketwatch.com/story/cvrs-could-become-a-new-trend-in-biotech-ma-2011-01-10
After what Berger just did? The takeover crowd have packed their bags and left the building.. Unless, Harvey stumbles..
Looks like we will surpass 10 million shares. Will that be the the record for one day?
As I said, priced within hours, and BIG! Who ever said 10 million shares doesn't know the Harvey way..
I do think they will be aggressive with this dilution. No mamby pamby 10 million shares.. And, they have to do it in hours, not days.. Otherwise, Mr. Market will lean hard....